Login

Alexandre Fraichard, CEO, Genoway 00:00:00

Share On Facebook Share On Twitter

Interview of Alexandre Fraichard, CEO of Genoway

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
William Huang, chairman and CEO of GDS Holdings Ltd., outlines his growth strategy for the Chinese data center company.
00:10:00
Join Elizabeth Burton, MD & Client Investment Strategist at Goldman Sachs Asset Management, as she navigates the complexities of the fundraising climate.
00:00:00
Genetic Technologies building pathway to profitability - Simon Morriss, CEO, Genetic Technologies Ltd
00:10:00
What is the Endowment Investment Philosophy | Prateek Mehrotra, CIO , Endowment Wealth Management.
00:10:00
Astra Exploration CEO Brian Miller Discusses Phase 2 Drilling Results and Project Potential
00:10:00
The Secrets to Raising Money|Ariel Sterman,Vice President,Bessemer Venture Partners
00:10:00
Aligned Capital Partners: Elevating Financial Advisory with UNIVERIS Innovation
00:00:00
Lloyd Diamond - Pixium Vision CEO, Pixium Vision
00:10:00
Fuller Industrial: Comprehensive Solutions for Cost-Efficient Global Operations
00:10:00
Logistics Emerges as Key Driver in South Africa's Economic Recovery Amidst Ecommerce Surge | Steven Brown , CEO, Fortress Real Estate Investments Ltd.
00:10:00
Reimagining the Workplace: Brent Saunders on the Permanent Shift to Remote Work |Brent Saunders , CEO, Bausch + Lomb Corp.
00:10:00
Johnny Unleashes Innovation: Badger Infrastructure Solutions Spotlighted at The Utility Expo | Rob Blackadar - CEOof Badger

© 2026 Nehu